🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

21 recruiting trials

for Pollen Allergy

Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis NCT04815668NA1 site📍 Beijing Guang'anmen Hospital of China Academy of Chinese Medical Sc… · Tests: Acupuncture group, Placebo acupuncture group, Rescue medication group Identification of B Regulatory Cells by Flow Cytometry NCT06876506n/a1 site📍 Hull Hull University Teaching Hospitals NHS Trust · Tests: Venepuncture, Allergen Specific Immunotherapy, Allergen Specific Immunotherapy PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis NCT07563439Phase 21 site📍 Almaty Kazakh National Agrarian University · Tests: Recombinant Artemisia vulgaris allergen Art v 1 with Montanide ISA-51 adjuvant, Montanide ISA-51 placebo emulsion GRASS (Grass MATA MPL Real-world Assessment Study) NCT07412990n/a1 site📍 Hamburg Allergy Therapeutics · Tests: Grassmuno® Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study NCT07055542NA6 sites📍 Albury📍 Box Hill📍 Clayton University of Melbourne · Tests: Observational Investigating Nasal and Ocular Immune Response to Conjunctival Allergen Exposure NCT07801625n/a1 site📍 Kingston Dr. Anne Ellis · Tests: Standardized Allergen Extract, Timothy Grass (Phleum pratense), Standardized Allergen Extract, Timothy Grass (Phleum pr… The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy NCT04544774n/a2 sites📍 Leuven📍 Bruges Universitaire Ziekenhuizen KU Leuven · Tests: AIT, NAPT Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis NCT07678931Phase 327 sites📍 Beijing📍 Beijing📍 Beijing Chengdu Kangnuoxing Biopharma,Inc. · Tests: Stapokibart, Placebo Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preliminary Immunogenicity of ITI-9001 in Japanese Patients With Japanese Red Cedar (JRC) Pollinosis NCT07726147Phase 11 site📍 Tokyo Immunomic Therapeutics, Inc. · Tests: ITI-9001, Placebo Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis NCT06846385Phase 2, Phase 31 site📍 Beijing Shanghai Mabgeek Biotech.Co.Ltd · Tests: Placebo, MG-K10 Humanized Monoclonal Antibody Injection Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis NCT07588672NA5 sites📍 Normal📍 St Louis📍 Ocean City Polyrizon Ltd. · Tests: PL-14 Allergy Blocker, Ayr® Saline Nasal Mist A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis NCT07154342Phase 31 site📍 Wuhan Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Tests: GR1802 injection, Placebo A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure NCT07219849Phase 21 site📍 Mississauga Alixer Nexgen Therapeutics Limited · Tests: ALDP001 Nasal Spray, Placebo Nasal spray Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis NCT07711262Phase 318 sites📍 Baoding📍 Cangzhou📍 Shijiazhuang Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. · Tests: Rupatifen Fumarate Capsules, Rupatadine Fumarate Tablets, Rupatifen Fumarate Capsules Placebo, Rupatadine Fumarate Tabl… Quercus Ilex and Quercus Robur Allergen Extracts Standardisation NCT05532566NA1 site📍 Madrid Inmunotek S.L. · Tests: Allergenic extract Evaluation of the Efficacy of Oral Immunotherapy With Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study NCT06771791Phase 34 sites📍 Strasbourg📍 Besançon📍 Dijon University Hospital, Strasbourg, France · Tests: oral provocation test Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium NCT06714149NA1 site📍 Leuven prof. dr. Rik Schrijvers · Tests: Immunoreactivity testing, Immunoreactivity testing (negative control) Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis NCT07398859Phase 230 sites📍 Beijing📍 Beijing📍 Beijing Shanghai Chia Tai Tianqing Pharmaceutical Technology Develo… · Tests: TQH2722 injection Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project NCT07419230NA1 site📍 Madrid Fundación de Investigación Biomédica - Hospital Universitar… · Tests: Active Adherence-booster App, Inactive Adherence-booster App Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen NCT04891237Phase 332 sites📍 Tarancón📍 Alcalá de Henares📍 Tres Cantos Inmunotek S.L. · Tests: 10,000 MG01 + 10,000 T517, 30,000 MG01 + 10,000 T517, Placebo Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis NCT06300203Phase 21 site📍 Beijing Beijing Tongren Hospital · Tests: Interleukin-4 receptor responders, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy